Medical resource utilization and costs among Australian patients with genotype 1 chronic hepatitis C: results of a retrospective observational study.
CONCLUSIONS: CHC-related MRU increases substantially with disease severity. These real-world MRU data for GT1 CHC will be valuable in assessing the impact of new hepatitis C treatments.
PMID: 27552282 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Economics | Health Management | Hepatitis | Hepatitis C | Hospital Management | Incivek | Liver | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology